What is the ticker symbol for Arcutis Biotherapeutics?

Arcutis Biotherapeutics trades under the ticker ARQT on NASDAQ.

What sector does Arcutis Biotherapeutics operate in?

Arcutis Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ARQT in a portfolio?

PortView shows ARQT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Arcutis Biotherapeutics (ARQT) Stock Analysis

NASDAQHealthcareBiotechnology

$23.85+0.44%

1-year price historyRange $15.94 – $31.20

52-week range$23.85

$15.13$31.77

What Arcutis Biotherapeutics does

Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.

Key metrics

Market cap

$2.98B

P/E (TTM)

113.59

EPS (TTM)

$0.21

Beta

1.53

Dividend yield

0.00%

Revenue / share

$3.55

50-day avg

$26.55

200-day avg

$25.62

52-week high

$31.77

52-week low

$15.13

CEO

Todd Franklin Watanabe

ETFs linked to ARQT

Broad-market and Healthcare sector ETFs an investor holding Arcutis Biotherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ARQT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ARQT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Arcutis Biotherapeutics?: Arcutis Biotherapeutics trades under the ticker ARQT on NASDAQ.
Which exchange is ARQT listed on?: ARQT is listed on NASDAQ.
What sector does Arcutis Biotherapeutics operate in?: Arcutis Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ARQT in a portfolio?: PortView shows ARQT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.